1560
We report a myeloma patient who developed severe paralytic ileus during bortezomib therapy, which presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation, suggesting a direct causal relationship.
 a myeloma patient: Subject; paralytic ileus: Effect; presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation: Effect; bortezomib therapy: Treatment; myeloma: Treatment.Disorder; bortezomib: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a myeloma patient: Subject; paralytic ileus: Effect; presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation: Effect; bortezomib therapy: Treatment; myeloma: Treatment.Disorder; bortezomib: Treatment.Drug